AP sources say the policy would tell FDA not to act against pharmacies compounding peptides like BPC-157, after staff raised safety concerns.
Recap by typeshit. Full story at ABC News - Breaking News, Latest News and Videos.
Lincoln Journal Star reports FDA advisors are weighing whether seven unapproved peptides can be used in some compounded prescriptions.
MedPro Group points to an HHS move letting pharmacies compound six peptides that lack FDA approval. Details are in the linked story.
The segment covers a federal draft policy that could open access to some injectable peptides, alongside proposed changes to infant formula nutrients.
The longevity researcher argues the FDA system has grown too slow and costly, saying it favors big drugmakers. He offers this as the reason reform efforts emerged.
Researchers in Drugs & Therapy Perspectives looked at nearly 108,000 participants and saw the same rate of suicidal ideation or behavior on GLP-1s as on placebo.
GEN's A-List has Mounjaro nearly doubling and passing Ozempic, while Zepbound grew 174.9% to take the No. 10 spot and Wegovy landed at No. 11.
Loading…